Phase II Diabetes Data Heighten Incyte’s Partnership Appeal
This article was originally published in The Pink Sheet Daily
Novel compound that acts on cortisol gives DPP-4 inhibitors a run for their money.
You may also be interested in...
Liraglutide’s cardiovascular safety profile gets support from a majority of an FDA advisory committee, but a preclinical thyroid cancer risk results in a tied vote on the approvability of Novo Nordisk’s type 2 diabetes drug.
Phase IIb RA studies launch later this year; myelofibrosis update set for December ASH meeting.
FDA issues Medwatch alert warning health care professionals of 30 cases of acute pancreatitis in patients taking the type 2 diabetes drug